Showing results (471-480 of 640) with videos related to

Sort By:
Pageof 64
BMC Genomics|November 28, 2025
Genomic characterization of clinical Borrelia burgdorferi sensu lato isolates in the Netherlands over a thirty-year periodZhenghui Li, Jonathan T Lee, Varun Raghuraman, et al.
Therapeutic Advances in Neurological Disorders|July 7, 2025
Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label studyMiriam Freimer, Urvi Desai, Raghav Govindarajan, et al.
BMC Infectious Diseases|November 23, 2019
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?Urvi Rana, Matt Driedger, Paul Sereda, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patientsUrvi Rana, Matt Driedger, Paul Sereda, et al.
Journal of Lipid Research|June 23, 2009
GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4William K Sonnenburg, Daiguan Yu, E-Chiang Lee, et al.
Blood Cancer Journal|August 22, 2022
Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disasterRachel Zeig-Owens, David G Goldfarb, Benjamin J Luft, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer ImmunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumorsIrene Orlow, Bernard J Park, Urvi Mujumdar, et al.
Pageof 64